In OS, activation of cGAS–STING can enhance antigen presentation and recruit T cells into the bone tumor microenvironment, providing a mechanistic basis for combinations with chemotherapy/radiotherapy or checkpoint blockade (109). The gene discussed is STING1; the disease is bone neoplasm.